Benitec Biopharma Price to Free Cash Flow Ratio 2014-2022 | BNTC

Historical price to free cash flow ratio values for Benitec Biopharma (BNTC) since 2014. For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Benitec Biopharma Price to Free Cash Flow Ratio Historical Data
Date Stock Price TTM FCF per Share Price to FCF Ratio
2022-08-08 0.78 0.00
2022-03-31 2.34 $-542.31 0.00
2021-12-31 2.62 $-517.77 0.00
2021-09-30 3.57 $-290.00 0.00
2021-06-30 4.25 $-607.82 0.00
2021-03-31 5.17 $-995.84 0.00
2020-12-31 3.00 $-1,649.68 0.00
2020-09-30 6.28 $-1,918.05 0.00
2020-06-30 7.91 $-1,499.45 0.00
2020-03-31 3.93 $-845.62 0.00
2019-09-30 7.11 $-137.50 0.00
2017-09-30 21.70 $-10.69 0.00
2016-09-30 14.00 $-7.13 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.006B $0.000B
Benitec Biopharma Limited is a biotechnology company which developed a patented gene silencing technology delivered by gene therapy called DNA directed RNA interference. The company is developing ddRNAi-based therapeutics for chronic and life-threatening human conditions including hepatitis C and B, drug resistant lung cancer and wet age-related macular degeneration. Benitec Biopharma Limited is based in Sydney, Australia.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $157.582B 9.56
GSK (GSK) United Kingdom $81.978B 9.84
Bio-Rad Laboratories (BIO.B) United States $16.008B 35.37
QIAGEN (QGEN) Netherlands $11.229B 18.80
Biohaven Pharmaceutical Holding (BHVN) United States $10.520B 0.00
Ginkgo Bioworks Holdings (DNA) United States $5.756B 0.00
Arcus Biosciences (RCUS) United States $1.974B 38.52
Emergent Biosolutions (EBS) United States $1.523B 8.83
Myovant Sciences (MYOV) United Kingdom $1.503B 0.00
Zymeworks (ZYME) Canada $0.405B 0.00
Enzo Biochem (ENZ) United States $0.125B 0.00
SQZ Biotechnologies (SQZ) United States $0.098B 0.00
Gelesis Holdings (GLS) United States $0.098B 0.00
Ambrx Biopharma (AMAM) United States $0.092B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.000B 0.00